Towards improved shRNA and miRNA reagents as inhibitors of HIV1 replication

Future Microbiology

Volumn 9, Issue 4, 2014, Pages 561-571

  Berkhout, Ben ^a   Liu, Ying Poi ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

antiviral drugs; cure for aids; drug resistance; gene therapy; HIV1; lentiviral vector; miRNA; RNAi; shRNA; virus evolution

Indexed keywords

DICER; MICRORNA; MICRORNA 451; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; SMALL INTERFERING RNA;

BIOSYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULE; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; VIRAL GENE THERAPY; VIRUS ENTRY; VIRUS REPLICATION; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PROCEDURES;

ANTI-HIV AGENTS; DRUG DISCOVERY; HIV-1; HUMANS; MICRORNAS; RNA, SMALL INTERFERING; VIRUS REPLICATION;

EID: 84900321291     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.14.5     Document Type: Review

References (96)

1. Han J, Lee Y, Yeom KH et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125(5), 887-901 (2006).
2. Auyeung VC, Ulitsky I, McGeary SE, Bartel DP. Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing. Cell 152(4), 844-858 (2013).
3. Chendrimada TP, Gregory RI, Kumaraswamy E et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436(7051), 740-744 (2005).
4. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 115(7), 787-798 (2003).
5. Kalinski P, Schuitemaker JH, Hilkens CM, Kapsenberg ML. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a-CD83-dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161(6), 2804-2809 (1998).
6. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304(5670), 594-596 (2004).
7. Li Y, Lu J, Han Y, Fan X, Ding SW. RNA interference functions as an antiviral immunity mechanism in mammals. Science 342(6155), 231-234 (2013).
8. Maillard PV, Ciaudo C, Marchais A et al. Antiviral RNA interference in mammalian cells. Science 342(6155), 235-238 (2013).
9. Okamura K, Hagen JW, Duan H, Tyler DM, Lai EC. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 130(1), 89-100 (2007).
10. Ruby JG, Jan CH, Bartel DP. Intronic microRNA precursors that bypass Drosha processing. Nature 448(7149), 83-86 (2007).
11. Havens MA, Reich AA, Duelli DM, Hastings ML. Biogenesis of mammalian microRNAs by a non-canonical processing pathway. Nucleic Acids Res. 40(10), 4626-4640 (2012).
12. Bogerd HP, Karnowski HW, Cai X, Shin J, Pohlers M, Cullen BR. A mammalian herpes virus uses noncanonical expression and processing mechanisms to generate viral MicroRNAs. Mol. Cell 37(1), 135-142 (2010).
13. Pfeffer S, Zavolan M, Grasser FA et al. Identification of virus-encoded microRNAs. Science 304(5671), 734-736 (2004).
14. Miyoshi K, Miyoshi T, Siomi H. Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production. Mol. Genet. Genomics 284(2), 95-103 (2010).
15. Yang JS, Lai EC. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol. Cell 43(6), 892-903 (2011).
16. Cole C, Sobala A, Lu C et al. Filtering of deep sequencing data reveals the existence of abundant Dicer-dependent small RNAs derived from tRNAs. RNA. 15(12), 2147-2160 (2009).
17. Kawaji H, Nakamura M, Takahashi Y et al. Hidden layers of human small RNAs. BMC Genomics 9, 157 (2008).
18. Langenberger D, Bermudez-Santana CI, Stadler PF, Hoffmann S. Identification and classification of small RNAs in transcriptome sequence data. Pac. Symp. Biocomput. 80-87 (2010).
19. Persson H, Kvist A, Vallon-Christersson J, Medstrand P, Borg A, Rovira C. The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs. Nat. Cell Biol. 11(10), 1268-1271 (2009).
20. Friedlander MR, Mackowiak SD, Li N, Chen W, Rajewsky N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 40(1), 37-52 (2012).
21. Langenberger D, Cakir MV, Hoffmann S, Stadler PF. Dicer-processed small RNAs: rules and exceptions. J. Exp. Zool. B Mol. Dev. Evol. 320(1), 35-46 (2013).
22. Diederichs S, Haber DA. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131(6), 1097-1108 (2007).
23. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6(5), 376-385 (2005).
24. Cheloufi S, Dos Santos CO, Chong MM, Hannon GJ. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 465(7298), 584-589 (2010).
25. Siolas D, Lerner C, Burchard J et al. Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol. 23(2), 227-231 (2005).
26. Cifuentes D, Xue H, Taylor DW et al. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 328(5986), 1694-1698 (2010).
27. Yang JS, Lai EC. Dicer-independent, Ago2-mediated microRNA biogenesis in vertebrates. Cell Cycle 9(22), 4455-4460 (2010).
28. Maniataki E, Mourelatos Z. A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev. 19(24), 2979-2990 (2005).
29. Liu X, Jin DY, McManus MT, Mourelatos Z. Precursor microRNA-programmed silencing complex assembly pathways in mammals. Mol. Cell 46(4), 507-517 (2012).
30. Tan GS, Garchow BG, Liu X et al. Expanded RNA-binding activities of mammalian Argonaute 2. Nucleic Acids Res. 37(22), 7533-7545 (2009).
31. Tan GS, Garchow BG, Liu X, Metzler D, Kiriakidou M. Clarifying mammalian RISC assembly in vitro. BMC. Mol. Biol. 12, 19 (2011).
32. Li N, You X, Chen T et al. Global profiling of miRNAs and the hairpin precursors: insights into miRNA processing and novel miRNA discovery. Nucleic Acids Res. 41(6), 3619-3634 (2013).
33. Shen B, Goodman HM. Uridine addition after microRNA-directed cleavage. Science 306(5698), 997 (2004).
34. Yang JS, Maurin T, Lai EC. Functional parameters of Dicer-independent microRNA biogenesis. RNA 18(5), 945-957 (2012).
35. Yang JS, Maurin T, Robine N et al. Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2- mediated microRNA biogenesis. Proc. Natl Acad. Sci. USA 107(34), 15163-15168 (2010).
36. Dueck A, Ziegler C, Eichner A, Berezikov E, Meister G. microRNAs associated with the different human Argonaute proteins. Nucleic Acids Res. 40(19), 9850-9862 (2012).
37. Tolia NH, Joshua-Tor L. Slicer and the argonautes. Nat. Chem. Biol. 3(1), 36-43 (2007).
38. McManus MT, Petersen CP, Haines BB, Chen J, Sharp PA. Gene silencing using micro-RNA designed hairpins. RNA 8(6), 842-850 (2002).
39. Harborth J, Elbashir SM, Vandenburgh K et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13(2), 83-105 (2003).
40. Ge Q, Ilves H, Dallas A et al. Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity. RNA 16(1), 106-117 (2010).
41. McIntyre GJ, Yu YH, Lomas M, Fanning GC. The effects of stem length and core placement on shRNA activity. BMC Mol. Biol. 12, 34 (2011).
42. Dallas A, Ilves H, Ge Q et al. Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencing. Nucleic Acids Res. 40, 9255-9271 (2012).
43. Schopman NC, Liu YP, Konstantinova P, Ter Brake O, Berkhout B. Optimization of shRNA inhibitors by variation of the terminal loop sequence. Antiviral Res. 86(2), 204-211 (2010).
44. Vermeulen A, Behlen L, Reynolds A et al. The contributions of dsRNA structure to Dicer specificity and efficiency. RNA 11(5), 674-682 (2005).
45. Trabucchi M, Briata P, Garcia-Mayoral M et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459(7249), 1010-1014 (2009).
46. Jensen SM, Schmitz A, Pedersen FS, Kjems J, Bramsen JB. Functional selection of shRNA loops from randomized retroviral libraries. PLoS ONE 7(8), e43095 (2012).
47. Liu YP, von Eije KJ, Schopman NC et al. Combinatorial RNAi against HIV 1 using extended short hairpin RNAs. Mol. Ther. 17(10), 1712-1723 (2009).
48. Liu YP, Schopman NC, Berkhout B. Dicer-independent processing of short hairpin RNAs. Nucleic Acids Res. 41(6), 3723-3733 (2013).
49. Coley W, Van DR, Carpio L et al. Absence of DICER in monocytes and its regulation by HIV 1. J. Biol. Chem. 285(42), 31930-31943 (2010).
50. Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34(3), 263-264 (2003).
51. Gu S, Jin L, Zhang Y et al. The loop position of shrnas and pre-mirnas is critical for the accuracy of dicer processing in vivo. Cell 151(4), 900-911 (2012).
52. Fukunaga R, Han BW, Hung JH, Xu J, Weng Z, Zamore PD. Dicer partner proteins tune the length of mature miRNAs in flies and mammals. Cell 151(3), 533-546 (2012).
53. Lee HY, Zhou K, Smith AM, Noland CL, Doudna JA. Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing. Nucleic Acids Res. 41(13), 6568-6576 (2013).
54. Berkhout B, Jeang KT. MicroRNAs in viral gene regulation. Biochim. Biophys. Acta 1809(11-12), 587 (2011).
55. Berkhout B, Jeang KT. RISCy business: microRNAs, pathogenesis, and viruses. J. Biol. Chem. 282(37), 26641-26645 (2007).
56. Huang J, Wang F, Argyris E et al. Cellular microRNAs contribute to HIV 1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13(10), 1241-1247 (2007).
57. Schopman NC, Willemsen M, Liu YP et al. Deep sequencing of virus-infected cells reveals HIV encoded small RNAs. Nucleic Acids Res. 40(1), 414-427 (2012).
58. Klase Z, Houzet L, Jeang KT. MicroRNAs and HIV 1: complex interactions. J. Biol. Chem. 287(49), 40884-40890 (2012).
59. Narayanan A, Kehn-Hall K, Bailey C, Kashanchi F. Analysis of the roles of HIV derived microRNAs. Expert. Opin. Biol. Ther. 11(1), 17-29 (2011).
60. Bennasser Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV 1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22(5), 607-619 (2005).
61. Schnettler E, de Vries W, Hemmes H et al. The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV 1 Tat. EMBO Rep. 10(3), 258-263 (2009).
62. Liu YP, Westerink JT, Ter Brake O, Berkhout B. RNAi-inducing lentiviral vectors for anti-HIV 1 gene therapy. Methods Mol. Biol. 721, 293-311 (2011).
63. Knoepfel SA, Centlivre M, Liu YP, Boutimah F, Berkhout B. Selection of RNAi-based inhibitors for anti-HIV gene therapy. World J. Virol. 1(3), 79-90 (2012).
64. Kumar P, Ban HS, Kim SS et al. T cell-specific siRNA delivery suppresses HIV 1 infection in humanized mice. Cell 134, 577-586 (2008).
65. Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem. Biol. 19(1), 60-71 (2012).
66. Aiuti A, Biasco L, Scaramuzza S et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341, 865 (2013).
67. Biffi A, Montini E, Lorioli L et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341, 864 (2013).
68. Cartier N, Hacein-Bey-Abina S, Bartholomae CC et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326(5954), 818-823 (2009).
69. Liu YP, Vink MA, Westerink JT et al. Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies. RNA 16, 1328-1339 (2010).
70. Ter Brake O, Berkhout B. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions. J. Gene Med. 9(9), 743-750 (2007).
71. Westerhout EM, Berkhout B. A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res. 35(13), 4322-4330 (2007).
72. Low JT, Knoepfel SA, Watts JM, Ter BO, Berkhout B, Weeks KM. SHAPE-directed discovery of potent shRNA inhibitors of HIV 1. Mol. Ther. 20, 820-828 (2012).
73. ter Brake O, Berkhout B. Development of an RNAi-based gene therapy against HIV 1. In: Therapeutic Oligonucleotides. Kurreck J (Ed.). RSC Publishing, London, UK, 296-311 (2008).
74. Das AT, Brummelkamp TR, Westerhout EM et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78(5), 2601-2605 (2004).
75. Ter Brake O, Konstantinova P, Ceylan M, Berkhout B. Silencing of HIV 1 with RNA interference: a multiple shRNA approach. Mol. Ther. 14(6), 883-892 (2006).
76. DiGiusto DL, Krishnan A, Li L et al. RNA-based gene therapy for HIV with lentiviral vector-modified CD34-cells in patients undergoing transplantation for AIDS-related lymphoma. Sci. Transl. Med. 2(36), 36ra43 (2010).
77. Shah PS, Pham NP, Schaffer DV. HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites. Mol. Ther. 20(4), 840-848 (2012).
78. Herrera-Carrillo E, Liu YP, Berkhout B. The impact of unprotected T cells in RNAi-based gene therapy for HIV AIDS. Mol. Ther. 22(3), 596-606 (2013).
79. Cannon P, June C. Chemokine receptor 5 knockout strategies. Curr. Opin. HIV AIDS 6(1), 74-79 (2011).
80. Li L, Krymskaya L, Wang J et al. Genomic editing of the HIV 1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases. Mol. Ther. 21(6), 1259-1269 (2013).
81. Voit RA, McMahon MA, Sawyer SL, Porteus MH. Generation of an HIV resistant T-cell line by targeted 'stacking' of restriction factors. Mol. Ther. 21(4), 786-795 (2013).
82. Anderson J, Li MJ, Palmer B et al. Safety and efficacy of a lentiviral vector containing three anti-HIV genes-CCR5 ribozyme, tat-rev siRNA, and TAR decoy-in SCID-hu mouse-derived T cells. Mol. Ther. 14, 1182-1188 (2007).
83. Mitsuyasu RT, Merigan TC, Carr A et al. Phase II gene therapy trial of an anti-HIV ribozyme in autologous CD34-cells. Nat. Med. 15, 285-292 (2009).
84. Neff CP, Zhou J, Remling L et al. An aptamer-siRNA chimera suppresses HIV 1 viral loads and protects from helper CD4-Tcell decline in humanized mice. Sci. Transl. Med. 3(66), 66ra6 (2011).
85. Hildinger M, Dittmar MT, Schult-Dietrich P et al. Membrane-anchored peptide inhibits human immunodeficiency virus entry. J. Virol. 75(6), 3038-3042 (2001).
86. Ter Brake O, 't Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV 1 inhibition. Mol. Ther. 16(3), 557-564 (2008).
87. Saayman S, Arbuthnot P, Weinberg MS. Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors. Nucleic Acids Res. 38(19), 6652-6663 (2010).
88. Saayman S, Barichievy S, Capovilla A, Morris KV, Arbuthnot P, Weinberg MS. The efficacy of generating three independent anti-HIV 1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA. PLoS ONE 3(7), e2602 (2008).
89. Liu YP, Haasnoot J, Ter Brake O, Berkhout B, Konstantinova P. Inhibition of HIV 1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res. 36(9), 2811-2824 (2008).
90. Snyder LL, Ahmed I, Steel LF. RNA polymerase III can drive polycistronic expression of functional interfering RNAs designed to resemble microRNAs. Nucleic Acids Res. 37(19), e127 (2009).
91. Liu YP, Haasnoot J, Berkhout B. Design of extended short hairpin RNAs for HIV 1 inhibition. Nucleic Acids Res. 35(17), 5683-5693 (2007).
92. Konstantinova P, De Vries W, Haasnoot J, Ter Brake O, De Haan P, Berkhout B. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene Ther. 13(19), 1403-1413 (2006).
93. Zhou J, Rossi JJ. Current progress in the development of RNAi-based therapeutics for HIV 1. Gene Ther. 18(12), 1134-1138 (2011).
94. Centlivre M, Legrand N, Klamer S et al. Preclinical in vivo evaluation of the safety of a multi-shRNA-based gene therapy against HIV 1. Mol. Ther. Nucleic Acids 2, e120 (2013).
95. Maurin T, Cazalla D, Yang S Jr, Bortolamiol-Becet D, Lai EC. RNase III-independent microRNA biogenesis in mammalian cells. RNA 18(12), 2166-2173 (2012).
96. Castellano L, Stebbing J. Deep sequencing of small RNAs identifies canonical and non-canonical miRNA and endogenous siRNAs in mammalian somatic tissues. Nucleic Acids Res. 41(5), 3339-3351 (2013).